NCT 127's concert in Indonesia wraps up early due to safety hazards

NCT 127 Picture Courtesy: PR

NCT 127's concert in Jakarta, Indonesia had to wrap up earlier than expected due to multiple safety hazards. On November 4, NCT 127 held the first night of their 'Neo City : The Link' concert at the Indonesia Convention Exhibition.

Panic ensued when a bomb threat was made ahead of the concert, but on investigation the police found no explosives. Later, as fans tried to get closer to the artistes reportedly 30 fans fainted and were rushed to the hospital.

The organizer of NCT 127's Jakarta concert has now released a statement-

"Hello, we are from Dyandra Global Edutainment. Below is our explanation regarding the halt of the NCT 127 2ND TOUR "NEO CITY : JAKARTA - THE LINK" concert on November 4 and the announcement for the November 5 show. We have been informed about the general rules and safety procedures in advance, as well as advising our security team to remain in an orderly manner while the show goes on. However, an unforeseen circumstance happened at the end of the show. Concert the standing section appeared to go unorganized, which resulted in chaos and eventually led to the halt of the show for the sake of their safety. We're very grateful that no one was injured. However, as we put the safety and security of the audience as our top priority, the halt of the show became inevitable. We're deeply sorry for everyone who came to our Day 1 show for not being able to enjoy the concert until the end. We would also like to apologize to all members of NCT 127 and SM Entertainment for not making the desired concert possible. To make amends for today's incident and give the best experience, we will add more paramedics and security personnel for the Day 2 show. We will continue to work closely with the local police and work as hard as we could to avoid any incidents from happening again. We also encouraged tomorrow's audience to maintain safety procedures during the event."

Also Read: TXT's Taehyun tests positive for Covid-19